Specialty Pharmacy Times and Zitter Health Insights Announce Specialty Pharmacy Patient Choice Awards Finalists
Finalists and winners in inaugural awards program to be honored at Asembia 2017
Based on results from the ZHI 2016 Patient Satisfaction Survey (January-December 2016), finalists were selected for achieving the highest overall patient satisfaction scores in one of two categories: PBM/Payer Specialty Pharmacy and non-PBM/Payer Specialty Pharmacy. Finalists and winners will be recognized at the Patient Choice Awards luncheon on May 2 at the 2017 Asembia Conference at the Wynn/Encore Resort in Las Vegas. Finalists are showcased in the March 2017 issue of Specialty Pharmacy Times® and winners will be recognized in the June 2017 issue.
The finalists are:
PBM/Payer Specialty Pharmacies:
- CVS Health
- Humana Specialty Pharmacy
- US Specialty Care
Non-PBM/Payer Specialty Pharmacies:
- Amber Enterprises, Inc
- BioPlus Specialty Pharmacy
- Credena Health, LLC
- PANTHERx Specialty Pharmacy
- Senderra Rx Specialty Pharmacy
“Along with our partner Zitter Health Insights, we congratulate the finalists of the first Patient Choice Awards for specialty pharmacies,” said Brian Haug, President, Pharmacy and Healthcare Communications, LLC. “These specialty pharmacies raise the bar on what it means to be patient-centric while assuring optimal patient outcomes. They have been recognized as finalists today for their ability to consistently deliver the best services and experiences for patients with complex diseases, improving their overall health and well-being.”
“Specialty Pharmacy Times® and Zitter Health Insights are pleased to recognize best-in-class customer satisfaction and overall patient care by specialty pharmacies with the Patient Choice Awards,” said John Monahan, CEO of ZHI. “We thank the following committee members, who, as specialty pharmacy experts, have provided their valuable insights in launching this inaugural awards program that is designed to recognize excellence.”
Patient Choice Awards committee members are:
- Adam Fein — President, Pembroke Consulting/DrugChannels
- Brian McCarthy — Chief Operating Officer, PCMA
- Eric Percher — Director, Equity Research Covering Pharmaceutical Supply Chain, Barclays
- Jon Hamrick — Chief Strategy Office, Therigy
- Matt Carpenter — Senior Director, Pfizer
- Thomas Cohn — Chief Strategy Officer, Asembia
About the ZHI Patient Satisfaction Survey
The ZHI Patient Satisfaction Survey was launched in 2015 and is representative of 80 percent of specialty pharmacies across the United States, with data collected quarterly. The survey data are used to create a syndicated benchmarking report that functions to assess patient satisfaction and customer loyalty across a variety of therapeutic categories.
Accrediting agencies are increasingly requiring specialty pharmacies to survey their patients, with minimal requirements. The ZHI Patient Satisfaction Survey is the first industry-wide patient satisfaction survey to provide objective, comparative assessments of all major specialty pharmacies. Syndicated, actionable research based on the responses of thousands of specialty pharmacy patients, the ZHI Patient Satisfaction Survey enables specialty pharmacies to comply with accrediting requirements, as well as to assess their own and their competitors’ performances.
About Specialty Pharmacy Times®
About Zitter Health Insights
# # #
Media Contacts:
Alana Suko Michelle Meppen Rotstain
Specialty Pharmacy Times® Zitter Health Insights
267-932-8760 x310 973-604-5860
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025